The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(N-butyl-2-[2-methoxy-4-(4-oxo-3,4-dihydroquinazolin-2-yl)phenoxy]acetamide) ID: ALA4550841
PubChem CID: 155554930
Max Phase: Preclinical
Molecular Formula: C21H23N3O4
Molecular Weight: 381.43
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CCCCNC(=O)COc1ccc(-c2nc3ccccc3c(=O)[nH]2)cc1OC
Standard InChI: InChI=1S/C21H23N3O4/c1-3-4-11-22-19(25)13-28-17-10-9-14(12-18(17)27-2)20-23-16-8-6-5-7-15(16)21(26)24-20/h5-10,12H,3-4,11,13H2,1-2H3,(H,22,25)(H,23,24,26)
Standard InChI Key: ZDXXHGCGMOPSSA-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
29.5784 -2.4433 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5773 -3.2628 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2853 -3.6718 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2835 -2.0344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9922 -2.4397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9910 -3.2649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7011 -3.6762 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.4169 -3.2669 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4181 -2.4417 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.7034 -2.0258 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1196 -3.6773 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1160 -4.4956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8217 -4.9061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5315 -4.4995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5312 -3.6780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8249 -3.2712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7035 -1.2086 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.2386 -4.9091 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.9469 -4.5016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6540 -4.9112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3623 -4.5037 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.6528 -5.7284 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.0694 -4.9133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2386 -3.2689 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.9466 -3.6770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.7778 -4.5058 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.4849 -4.9154 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.1932 -4.5079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
8 11 1 0
10 17 2 0
14 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
20 22 2 0
21 23 1 0
15 24 1 0
24 25 1 0
23 26 1 0
26 27 1 0
27 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 381.43Molecular Weight (Monoisotopic): 381.1689AlogP: 2.89#Rotatable Bonds: 8Polar Surface Area: 93.31Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 7.96CX Basic pKa: 4.07CX LogP: 2.53CX LogD: 2.44Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.59Np Likeness Score: -1.11
References 1. Sonawane V, Mohd Siddique MU, Jadav SS, Sinha BN, Jayaprakash V, Chaudhuri B.. (2019) Cink4T, a quinazolinone-based dual inhibitor of Cdk4 and tubulin polymerization, identified via ligand-based virtual screening, for efficient anticancer therapy., 165 [PMID:30665142 ] [10.1016/j.ejmech.2019.01.011 ]